MCC950 improved cardiac contractility, reduced cardiac hypertrophy and the fibrotic area, inhibited NLRP3 and caspase-1 expression, and suppressed inflammation in mice with MI and diabetes[40]. The gene discussed is CASP1; the disease is myocardial infarction.